TrialEuropean journal of nuclear medicine and molecular imaging2014

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study.

Giovanni Paganelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.